Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 18c, Revenues Beat; Offers FY21 EPS Mid-Point Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
- Stocks face worst month since September, yen swings after BoJ
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Zimmer Biomet (ZBH) PT Raised to $188 at Truist Securities Following Earnings
May 4, 2021 2:01 PM EDTTruist Securities analyst Kaila Krum raised the price target on Zimmer Biomet (NYSE: ZBH) to $188.00 (from $174.00) while maintaining a Buy rating.
The analyst commented, "Zimmer Biomet reported 1Q21 results with both revenue and adj. EPS above consensus. After focusing on the spinoff last quarter,... More
Zimmer Biomet (ZBH) PT Raised to $202 at Needham & Company Following Earnings
May 4, 2021 2:00 PM EDTNeedham & Company analyst Mike Matson raised the price target on Zimmer Biomet (NYSE: ZBH) to $202.00 (from $192.00) while maintaining a Strong Buy rating.
The analyst commented, "ZBH's 1Q21 revenue and EPS beat consensus. ZBH's underlying revenue growth improved in 1Q21, which we believe was... More
Wells Fargo Introduces 35 "Signature Picks" - Here's Which Stocks Made It
May 3, 2021 7:17 AM EDTChristopher Harvey, a senior research analyst at Wells Fargo, unveiled today the "Signature Picks" portfolio consisting of 35 stocks.
A portfolio, accessible under the Bloomberg ticker WFSSBEST Index, highlighting the banks "best stock ideas in a diversified, risk-adjusted package." The goal is to outperform the S&P500 over a 1-year period via stock selection, not sector rotation, Harvey writes in a note.
Signature Picks has no preordained style/factor biases (unlike our former model portfolio, the QQP). It is designed to be an eclectic/opportunistic portfolio with a... More
